©The Author(s) 2025.
World J Stem Cells. Dec 26, 2025; 17(12): 114349
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.114349
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.114349
Table 2 Methods to detect genetic stability of in vitro expanded mesenchymal stem cells
| Assay | What it detects | Strengths | Limitations | Suggested use/frequency | Ref. |
| Conventional karyotype (G-banding) | Large chromosomal abnormalities | Low cost; detects numerical and structural chromosomal abnormalities | Low resolution (approximately 5-10 Mb), not sufficient to predict full genetic stability, laborious | At master cell bank and before clinical release | [96-98] |
| FISH | Low mosaicism, minor structural abnormalities | Rapid, sensitive, easy data interpretation | The chromosomal aberration being searched for must be known beforehand | Not a screening technique, complementary to karyotyping for further proof of genotypic stability | [96-98] |
| M-FISH | Overall view of all chromosomes in a single assay | High resolution (approximately 1.5 Mb) | Highly expensive, difficult to analyze and interpret data | Not to be used to replace karyotyping | [96,99] |
| a-CGH | Copy number variations | Higher resolution than karyotype (≤ 50 kb), medium cost, no need for metaphases, requires only the genomic DNA | Cannot detect balanced translocations, inversion and intragenic rearrangement; need of experienced cytogenetic specialist | At defined passage thresholds and for new donor lines or when recurrent abnormalities are found | [96-98] |
| WGS | Single-nucleotide changes and copy number alterations | Highest resolution; comprehensive | Costly; complex analysis; uncertain clinical significance for many variants | As confirmatory test for master bank or if abnormalities suspected | [100] |
| Telomere length (qPCR) | Telomere attrition | Simple surrogate for replicative senescence | Not definitive for malignancy risk | Periodic, after a certain number of passages | [101] |
| DNA methylation profiling | Epigenetic drift; aging signatures | Useful for senescence, potency | Interpretation still evolving | For research and characterization; consider for potency correlation | [102-104] |
- Citation: Mayeen NF, Salma U, Abu Kasim NH, Mahmoud O, Haque N. Hurdles to overcome for mesenchymal stem cell translation from bench to bedside. World J Stem Cells 2025; 17(12): 114349
- URL: https://www.wjgnet.com/1948-0210/full/v17/i12/114349.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i12.114349